SurgOnc Today®
SurgOnc Today®
Society of Surgical Oncology
Peptide Receptor Radionuclide Therapy (PRRT): What Surgeons Need to Know
20 minutes Posted Nov 20, 2020 at 6:00 am.
0:00
20:36
Download MP3
Show notes

In this episode of SurgOnc Today™, Gastrointestinal Disease Site Work Group Chair, Vance Sohn, MD, discusses PRRT with SSO President, James Howe, MD and Thomas Clancy, MD from the Gastrointestinal Disease Site Work Group. They discuss the current indications, efficacy, and what the future holds for PRRT.